A framework for clinical utilization of robotic exoskeletons in rehabilitation

Exoskeletons are externally worn motorized devices that assist with sit-to-stand and walking in individuals with motor and functional impairments. The Food & Drug Administration (FDA) has approved several of these technologies for clinical use however, there is limited evidence to guide optimal utilization in every day clinical practice. With the diversity of technologies & equipment available, it presents a challenge for clinicians to decide which device to use, when to initiate, how to implement these technologies with different patient presentations, and when to wean off the devices. Thus, we present a clinical utilization framework specific to exoskeletons with four aims. These aims are to assist with clinical decision making of when exoskeleton use is clinically indicated, identification of which device is most appropriate based on patient deficits and device characteristics, providing guidance on dosage parameters within a plan of care and guidance for reflection following utilization. This framework streamlines how clinicians can approach implementation through the synthesis of published evidence with appropriate clinical assessment & device selection to reflection for success and understanding of these innovative & complex technologies.

Automated summary

Exoskeletons are external motorized devices that assist individuals with motor and functional impairments in sit-to-stand and walking. The lack of evidence makes it challenging for clinicians to determine the optimal utilization of exoskeletons in everyday clinical practice. Therefore, we present a clinical utilization framework to guide decision-making, device selection, dosage parameters, and reflection for success and understanding of these innovative technologies.